<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/'><id>tag:blogger.com,1999:blog-5538539029544017314.post2456658997811848145..comments</id><updated>2008-03-21T05:37:05.060-07:00</updated><title type='text'>Comments on Clinical Trials News: Peptimmune Completes Phase I Study With A Novel Pe...</title><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://clinicaltrialsweb.blogspot.com/feeds/2456658997811848145/comments/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5538539029544017314/2456658997811848145/comments/default'/><link rel='alternate' type='text/html' href='http://clinicaltrialsweb.blogspot.com/2008/03/peptimmune-completes-phase-i-study-with_21.html'/><author><name>RickyFan</name><email>noreply@blogger.com</email></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>0</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage></feed>